Skip to main content
. Author manuscript; available in PMC: 2025 Aug 26.
Published in final edited form as: Am J Vet Res. 2025 Mar 31;86(6):ajvr.25.02.0038. doi: 10.2460/ajvr.25.02.0038

Table 1—

Inter-rater agreement on each component of the canine chronic diagnosis inventory in each phase of the study, with pilot 1 data used to modify the instrument before pilot 2 was conducted.

Inter-rater agreement Intrarater agreement
Pilot 1 raters (N = 16)a Pilot 2 raters (N = 18)b Pilot 1 raters (N = 16)a Pilot 2 raters (N = 18)b
Health condition κ P value κ P value κ P value κ P value
Chronic allergic/inflammatory condition 0.36 .06 0.67 .004 0.72 .001 1.00 < .001
Malignant neoplasia 0.25 .09 0.82 < .001 0.59 .001 0.82 < .001
Canine chronic bronchitis −0.05 .75 1.00 < .001 0.64 .006 0.64 .004
Chronic kidney disease 0.84 < .001 0.61 .005 0.86 < .001 0.77 .001
Canine cognitive dysfunction −0.07 .73 1.00 < .001 1.00 < .001 1.00 < .001
Congestive heart failure −0.05 .81 1.00 < .001 1.00 < .001 1.00 < .001
Diabetes mellitus 0.47 < .001 1.00 < .001 0.64 .006 1.00 < .001
Chronic gastrointestinal disease 0.14 .40 0.77 .001 0.62 < .001 0.61 .005
Hyperadrenocorticism 0.50 .005 1.00 < .001 0.86 < .001 0.64 .004
Hypoadrenocorticism N/A N/A 1.00 < .001 N/A N/A 1.00 < .001
Hypothyroidism 0.33 .09 1.00 < .001 0.54 .03 1.00 < .001
Obesity 0.51 .002 0.77 .001 0.74 < .001 0.68 .002
Osteoarthritis 0.20 .13 1.00 < .001 0.81 < .001 1.00 < .001
Periodontal disease 0.18 .21 −0.24 .31 0.78 < .001 0.85 < .001
Seizure condition 1.00 < .001 1.00 < .001 1.00 < .001 1.00 < .001
Recurrent urinary tract infection 0.42 .01 0.87 < .001 0.83 < .001 0.75 .001

N/A = Not applicable.

a

Sixteen nonspecialist veterinarians participated in pilot 1.

b

Eighteen different nonspecialist veterinarians participated in pilot 2.